Audit & Feedback
- Clinical resources
- Case studies
- Peer discussion
Moderate Risk Example
Read through the following 3 cases to see various ways you might use the risk assessment tool in different situations.
Moderate Risk Case 1
James is a male patient aged 61 with 120/81 mm Hg blood pressure, total serum cholesterol of 6.9 mmol/L, HDL cholesterol of 1.5 mmol/L with no history of diabetes or family CVD. He is overweight with a BMI of 28, smokes socially on the weekend, and identifies as Aboriginal.
Feedback
The risk is moderate (13%), so medication is not recommended in the guidelines, unless there are additional risk factors or lifestyle change has been ineffective after 3-6 months.
Patients with established risk factors such as a strong family history or high risk ethnicity (including Aboriginal and Torres Strait Islander) are recommended to take medication at a lower risk level. Obesity in itself is not an independent predictor of CVD after blood pressure and cholesterol are taken into account, so is better thought of as a target for lifestyle change rather than a reason to start medication earlier when the Australian risk model is being used.
When it’s a grey kind of area the risk calculator helps give me an idea whether I should be using drug therapy
Open Peer Discussion- Clinical resources
- Case studies
- Peer discussion
Peer discussion
Moderate Risk Case 1
James is a male patient aged 61 with 120/81 mm Hg blood pressure, total serum cholesterol of 6.9 mmol/L, HDL cholesterol of 1.5 mmol/L with no history of diabetes or family CVD. He is overweight with a BMI of 28, smokes socially on the weekend, and identifies as Aboriginal.
Feedback
The risk is moderate (13%), so medication is not recommended in the guidelines, unless there are additional risk factors or lifestyle change has been ineffective after 3-6 months.
Patients with established risk factors such as a strong family history or high risk ethnicity (including Aboriginal and Torres Strait Islander) are recommended to take medication at a lower risk level. Obesity in itself is not an independent predictor of CVD after blood pressure and cholesterol are taken into account, so is better thought of as a target for lifestyle change rather than a reason to start medication earlier when the Australian risk model is being used.